Has Anne Stump received payments from drug or device companies?

Yes. Drug and device makers reported $1,973 in general payments to Anne Stump across 111 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anne Stump did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anne Stump come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anne Stump

Adolescent Medicine · Indianapolis, INNPI 1366489734

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.

$1,973in general payments, 2019–2025

Across 111 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$306
Tris Pharma Inc$269
Sanofi Pasteur Inc.$254
Merck$236
Pfizer$163
Neos Therapeutics, LP$125
plus $620 from 14 others

What the payments were for

Food & beverage$1,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	16	$306
Tris Pharma Inc	17	$269
Sanofi Pasteur Inc.	11	$254
Merck	13	$236
Pfizer	11	$163
Neos Therapeutics, LP	6	$125
GSK	7	$110
Supernus Pharmaceuticals, Inc.	5	$103
Ironshore Pharmaceuticals Inc.	6	$85
Adlon Therapeutics L.p.	4	$72
Kaleo, Inc.	2	$38
Seqirus USA Inc	2	$32
Cranial Technologies, Inc	2	$31
Collegium Pharmaceutical, Inc.	2	$30
Vertical Pharmaceuticals, LLC	2	$29
Shire North American Group Inc	1	$25
AstraZeneca	1	$21
Verrica Pharmaceuticals Inc.	1	$16
Sobi, Inc	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,973 in reported general payments places this provider in the 75th percentile of 21 adolescent medicine providers in Indiana.

See all adolescent medicine providers in Indiana →

Other adolescent medicine in Indianapolis

Mary OttIndianapolis$4K
Lanette Brown JonesIndianapolis$3K
Krista SantosIndianapolis$835
Rebekah WilliamsIndianapolis$159
Joyce Confer GillIndianapolis$121
Carolyn CurryIndianapolis$86
Lauren BellIndianapolis$46
Mary RouseIndianapolis$33
Eric MeiningerIndianapolis$15
Corrie HaysIndianapolis$11

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →